Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.26

+1.2%

Nov 11 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: rkrw who wrote (8227)	5/1/2003 12:56:05 AM
From: Miljenko Zuanic	Read Replies (3) of 52153

<<I was being somewhat facetious. What nbix has accomplished should serve as a model for all of biotech in how to build shareholder value and for biotech investors in what to look for in a biotech.>> Unfortunately, this model (visible from CEPH and others) depend too much on LUCK. Did NBIX yet completed successful PII trial from its own pipeline? Miljenko

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next